Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Number 1 Top Cardiometabolic Story of 2023: Phase 2 trial with #retatrutide, a GIP-GLP-1-GCG receptor triple agonist, resulted in a mean weight reduction of 24.2% after 48 weeks
Lancet Diabetes Endocrinol 5:341354 Athauda D, Maclagan K, Skene SS, et al (2017) Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial
separate if possible Proton pump inhibitors : Long-term use may reduce magnesium absorption (MHRA Drug Safety Update), potentially increasing supplementation needs Diuretics : Particularly loop and thiazide diuretics can increase urinary magnesium losses Always consult the British National Formulary (BNF) or individual medication SmPCs for specific separation timing recommendations
Available online at: (Accessed on November 14, 2025)
Neuroendocrinology 64 , 131138 (1996)
Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Juurlink DN, Targownik LE, Turin TC, Paterson JM, Ernst P (2016) Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
